GSE14764: A prognostic gene expression index in ovarian cancer -...
In mzon7/MetaGxOvarian: Transcriptomic Ovarian Cancer Datasets
Description
Format
Details
Value
Description
Ovarian carcinoma has the highest mortality rate among gynaecological malignancies. In this project, we investigated the hypothesis that molecular markers are able to predict outcome of ovarian cancer independently of classical clinical predictors, and that these molecular markers can be validated using independent data sets. We applied a semi-supervised method for prediction of patient survival. Microarrays from a cohort of 80 ovarian carcinomas (TOC cohort) were used for the development of a predictive model, which was then evaluated in an entirely independent cohort of 118 carcinomas (Duke cohort). A 300-gene ovarian prognostic index (OPI) was generated and validated in a leave-one-out approach in the TOC cohort (Kaplan-Meier analysis, p = 0.0087). In a second validation step, the prognostic power of the OPI was confirmed in an independent data set (Duke cohort, p = 0.0063). In multivariate analysis, the OPI was independent of the post-operative residual tumour, the main clinico-pathological prognostic parameter with an adjusted hazard ratio of 6.4 (TOC cohort, CI 1.8-23.5, p = 0.0049) and 1.9 (Duke cohort, CI 1.2-3.0, p = 0.0068). We constructed a combined score of molecular data (OPI) and clinical parameters (residual tumour), which was able to define patient groups with highly significant differences in survival. The integrated analysis of gene expression data as well as residual tumour can be used for optimized assessment of the prognosis of platinum-taxol-treated ovarian cancer. As traditional treatment options are limited, this analysis may be able to optimize clinical management and to identify those patients who would be candidates for new therapeutic strategies.
Format
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
experimentData(eset):
Experiment data
Experimenter name: Denkert C, Budczies J, Darb-Esfahani S, Gy??rffy B et al. A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol 2009 Jun;218(2):273-80.
Laboratory: Denkert, Lage 2009
Contact information:
Title: A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
URL:
PMIDs: 19294737
Abstract: A 254 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
version:
2015-09-22 19:13:08
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
Details
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
assayData: 20967 features, 80 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
n events median 0.95LCL 0.95UCL
80.00 21.00 4.52 4.19 NA
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.00 20.75 40.50 40.50 60.25 80.00
sample_type:
tumor
80
histological_type:
clearcell endo mix other
2 6 1 2
ser undifferentiated
68 1
primarysite:
ov
80
summarygrade:
high low
54 26
summarystage:
early late
9 71
tumorstage:
1 2 3 4
8 1 69 2
substage:
a b c NA's
4 6 32 38
grade:
1 2 3
3 23 54
recurrence_status:
norecurrence recurrence NA's
50 26 4
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
210 660 1050 1011 1328 2190
vital_status:
deceased living
21 59
batch:
2004-09-29 2004-09-30 2004-10-01 2005-01-21 2005-01-25 2005-01-26 2005-01-28
1 2 6 4 7 8 10
2005-03-02 2006-07-26 2006-07-27 2006-07-28 2006-08-11 2006-08-18 2006-08-19
6 4 6 4 10 3 4
2006-08-21
5
uncurated_author_metadata:
title: ovarian cancer: O10///geo_accession: GSM368670///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368670/GSM368670.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O11///geo_accession: GSM368671///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 54///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368671/GSM368671.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O12///geo_accession: GSM368672///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 68///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368672/GSM368672.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O13///geo_accession: GSM368673///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368673/GSM368673.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O14///geo_accession: GSM368674///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 18///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368674/GSM368674.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O15///geo_accession: GSM368675///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 30///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368675/GSM368675.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O16///geo_accession: GSM368676///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368676/GSM368676.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O17///geo_accession: GSM368677///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 2b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368677/GSM368677.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O18///geo_accession: GSM368678///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 67///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368678/GSM368678.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O19///geo_accession: GSM368679///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 31///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368679/GSM368679.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O1///geo_accession: GSM368661///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 39///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368661/GSM368661.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O20///geo_accession: GSM368680///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368680/GSM368680.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O21///geo_accession: GSM368681///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368681/GSM368681.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O22///geo_accession: GSM368682///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368682/GSM368682.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O23///geo_accession: GSM368683///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368683/GSM368683.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O24///geo_accession: GSM368684///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368684/GSM368684.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O25///geo_accession: GSM368685///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368685/GSM368685.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O26///geo_accession: GSM368686///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr, clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368686/GSM368686.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O27///geo_accession: GSM368687///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368687/GSM368687.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O28///geo_accession: GSM368688///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368688/GSM368688.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O29///geo_accession: GSM368689///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368689/GSM368689.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O2///geo_accession: GSM368662///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368662/GSM368662.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O30///geo_accession: GSM368690///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368690/GSM368690.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O31///geo_accession: GSM368691///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368691/GSM368691.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O32///geo_accession: GSM368692///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368692/GSM368692.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O33///geo_accession: GSM368693///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368693/GSM368693.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O34///geo_accession: GSM368694///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368694/GSM368694.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O35///geo_accession: GSM368695///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 47///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368695/GSM368695.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O36///geo_accession: GSM368696///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 42///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368696/GSM368696.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O37///geo_accession: GSM368697///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 52///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368697/GSM368697.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O38///geo_accession: GSM368698///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368698/GSM368698.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O39///geo_accession: GSM368699///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368699/GSM368699.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O3///geo_accession: GSM368663///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: transitional cell ca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368663/GSM368663.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O40///geo_accession: GSM368700///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368700/GSM368700.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O41///geo_accession: GSM368701///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368701/GSM368701.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O42///geo_accession: GSM368702///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 32///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368702/GSM368702.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O43///geo_accession: GSM368703///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368703/GSM368703.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O44///geo_accession: GSM368704///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368704/GSM368704.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O45///geo_accession: GSM368705///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368705/GSM368705.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O46///geo_accession: GSM368706///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 73///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368706/GSM368706.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O47///geo_accession: GSM368707///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 53///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368707/GSM368707.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O48///geo_accession: GSM368708///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368708/GSM368708.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O49///geo_accession: GSM368709///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368709/GSM368709.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O4///geo_accession: GSM368664///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 14///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368664/GSM368664.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O50///geo_accession: GSM368710///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 55///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368710/GSM368710.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O51///geo_accession: GSM368711///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368711/GSM368711.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O52///geo_accession: GSM368712///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368712/GSM368712.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O53///geo_accession: GSM368713///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 44///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368713/GSM368713.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O54///geo_accession: GSM368714///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368714/GSM368714.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O55///geo_accession: GSM368715///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368715/GSM368715.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O56///geo_accession: GSM368716///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368716/GSM368716.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O57///geo_accession: GSM368717///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368717/GSM368717.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O58///geo_accession: GSM368718///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: sarcomatoid///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368718/GSM368718.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O59///geo_accession: GSM368719///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368719/GSM368719.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O5///geo_accession: GSM368665///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368665/GSM368665.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O60///geo_accession: GSM368720///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368720/GSM368720.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O61///geo_accession: GSM368721///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368721/GSM368721.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O62///geo_accession: GSM368722///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368722/GSM368722.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O63///geo_accession: GSM368723///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368723/GSM368723.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O64///geo_accession: GSM368724///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368724/GSM368724.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O65///geo_accession: GSM368725///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368725/GSM368725.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O66///geo_accession: GSM368726///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368726/GSM368726.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O67///geo_accession: GSM368727///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 10///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368727/GSM368727.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O68///geo_accession: GSM368728///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368728/GSM368728.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O69///geo_accession: GSM368729///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 58///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368729/GSM368729.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O6///geo_accession: GSM368666///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368666/GSM368666.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O70///geo_accession: GSM368730///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368730/GSM368730.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O71///geo_accession: GSM368731///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 8///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368731/GSM368731.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O72///geo_accession: GSM368732///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368732/GSM368732.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O73///geo_accession: GSM368733///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: undifferentiated ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368733/GSM368733.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O74///geo_accession: GSM368734///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368734/GSM368734.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O75///geo_accession: GSM368735///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368735/GSM368735.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O76///geo_accession: GSM368736///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368736/GSM368736.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O77///geo_accession: GSM368737///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368737/GSM368737.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O78///geo_accession: GSM368738///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368738/GSM368738.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O79///geo_accession: GSM368739///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368739/GSM368739.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O7///geo_accession: GSM368667///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368667/GSM368667.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O80///geo_accession: GSM368740///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368740/GSM368740.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O8///geo_accession: GSM368668///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368668/GSM368668.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O9///geo_accession: GSM368669///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 70///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368669/GSM368669.cel.gz///data_row_count: 22283
1
duplicates:
GSE14764.GSE14764_GSM368667 GSE14764.GSE14764_GSM368668
1 1
NA's
78
Value
An expression set
mzon7/MetaGxOvarian documentation built on May 17, 2019, 10:39 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Format Details Value
Description
Ovarian carcinoma has the highest mortality rate among gynaecological malignancies. In this project, we investigated the hypothesis that molecular markers are able to predict outcome of ovarian cancer independently of classical clinical predictors, and that these molecular markers can be validated using independent data sets. We applied a semi-supervised method for prediction of patient survival. Microarrays from a cohort of 80 ovarian carcinomas (TOC cohort) were used for the development of a predictive model, which was then evaluated in an entirely independent cohort of 118 carcinomas (Duke cohort). A 300-gene ovarian prognostic index (OPI) was generated and validated in a leave-one-out approach in the TOC cohort (Kaplan-Meier analysis, p = 0.0087). In a second validation step, the prognostic power of the OPI was confirmed in an independent data set (Duke cohort, p = 0.0063). In multivariate analysis, the OPI was independent of the post-operative residual tumour, the main clinico-pathological prognostic parameter with an adjusted hazard ratio of 6.4 (TOC cohort, CI 1.8-23.5, p = 0.0049) and 1.9 (Duke cohort, CI 1.2-3.0, p = 0.0068). We constructed a combined score of molecular data (OPI) and clinical parameters (residual tumour), which was able to define patient groups with highly significant differences in survival. The integrated analysis of gene expression data as well as residual tumour can be used for optimized assessment of the prognosis of platinum-taxol-treated ovarian cancer. As traditional treatment options are limited, this analysis may be able to optimize clinical management and to identify those patients who would be candidates for new therapeutic strategies.
Format
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 | experimentData(eset):
Experiment data
Experimenter name: Denkert C, Budczies J, Darb-Esfahani S, Gy??rffy B et al. A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol 2009 Jun;218(2):273-80.
Laboratory: Denkert, Lage 2009
Contact information:
Title: A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
URL:
PMIDs: 19294737
Abstract: A 254 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
version:
2015-09-22 19:13:08
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
|
Details
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 | assayData: 20967 features, 80 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
n events median 0.95LCL 0.95UCL
80.00 21.00 4.52 4.19 NA
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.00 20.75 40.50 40.50 60.25 80.00
sample_type:
tumor
80
histological_type:
clearcell endo mix other
2 6 1 2
ser undifferentiated
68 1
primarysite:
ov
80
summarygrade:
high low
54 26
summarystage:
early late
9 71
tumorstage:
1 2 3 4
8 1 69 2
substage:
a b c NA's
4 6 32 38
grade:
1 2 3
3 23 54
recurrence_status:
norecurrence recurrence NA's
50 26 4
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
210 660 1050 1011 1328 2190
vital_status:
deceased living
21 59
batch:
2004-09-29 2004-09-30 2004-10-01 2005-01-21 2005-01-25 2005-01-26 2005-01-28
1 2 6 4 7 8 10
2005-03-02 2006-07-26 2006-07-27 2006-07-28 2006-08-11 2006-08-18 2006-08-19
6 4 6 4 10 3 4
2006-08-21
5
uncurated_author_metadata:
title: ovarian cancer: O10///geo_accession: GSM368670///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368670/GSM368670.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O11///geo_accession: GSM368671///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 54///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368671/GSM368671.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O12///geo_accession: GSM368672///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 68///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368672/GSM368672.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O13///geo_accession: GSM368673///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368673/GSM368673.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O14///geo_accession: GSM368674///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 18///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368674/GSM368674.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O15///geo_accession: GSM368675///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 30///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368675/GSM368675.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O16///geo_accession: GSM368676///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368676/GSM368676.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O17///geo_accession: GSM368677///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 2b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368677/GSM368677.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O18///geo_accession: GSM368678///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 67///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368678/GSM368678.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O19///geo_accession: GSM368679///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 31///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368679/GSM368679.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O1///geo_accession: GSM368661///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 39///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368661/GSM368661.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O20///geo_accession: GSM368680///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368680/GSM368680.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O21///geo_accession: GSM368681///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368681/GSM368681.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O22///geo_accession: GSM368682///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368682/GSM368682.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O23///geo_accession: GSM368683///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368683/GSM368683.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O24///geo_accession: GSM368684///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368684/GSM368684.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O25///geo_accession: GSM368685///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368685/GSM368685.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O26///geo_accession: GSM368686///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr, clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368686/GSM368686.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O27///geo_accession: GSM368687///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368687/GSM368687.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O28///geo_accession: GSM368688///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368688/GSM368688.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O29///geo_accession: GSM368689///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368689/GSM368689.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O2///geo_accession: GSM368662///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368662/GSM368662.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O30///geo_accession: GSM368690///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368690/GSM368690.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O31///geo_accession: GSM368691///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368691/GSM368691.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O32///geo_accession: GSM368692///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368692/GSM368692.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O33///geo_accession: GSM368693///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368693/GSM368693.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O34///geo_accession: GSM368694///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368694/GSM368694.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O35///geo_accession: GSM368695///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 47///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368695/GSM368695.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O36///geo_accession: GSM368696///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 42///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368696/GSM368696.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O37///geo_accession: GSM368697///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 52///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368697/GSM368697.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O38///geo_accession: GSM368698///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368698/GSM368698.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O39///geo_accession: GSM368699///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368699/GSM368699.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O3///geo_accession: GSM368663///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: transitional cell ca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368663/GSM368663.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O40///geo_accession: GSM368700///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368700/GSM368700.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O41///geo_accession: GSM368701///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368701/GSM368701.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O42///geo_accession: GSM368702///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 32///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368702/GSM368702.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O43///geo_accession: GSM368703///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368703/GSM368703.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O44///geo_accession: GSM368704///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368704/GSM368704.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O45///geo_accession: GSM368705///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368705/GSM368705.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O46///geo_accession: GSM368706///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 73///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368706/GSM368706.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O47///geo_accession: GSM368707///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 53///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368707/GSM368707.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O48///geo_accession: GSM368708///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368708/GSM368708.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O49///geo_accession: GSM368709///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368709/GSM368709.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O4///geo_accession: GSM368664///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 14///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368664/GSM368664.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O50///geo_accession: GSM368710///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 55///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368710/GSM368710.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O51///geo_accession: GSM368711///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368711/GSM368711.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O52///geo_accession: GSM368712///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368712/GSM368712.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O53///geo_accession: GSM368713///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 44///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368713/GSM368713.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O54///geo_accession: GSM368714///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368714/GSM368714.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O55///geo_accession: GSM368715///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368715/GSM368715.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O56///geo_accession: GSM368716///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368716/GSM368716.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O57///geo_accession: GSM368717///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368717/GSM368717.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O58///geo_accession: GSM368718///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: sarcomatoid///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368718/GSM368718.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O59///geo_accession: GSM368719///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368719/GSM368719.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O5///geo_accession: GSM368665///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368665/GSM368665.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O60///geo_accession: GSM368720///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368720/GSM368720.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O61///geo_accession: GSM368721///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368721/GSM368721.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O62///geo_accession: GSM368722///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368722/GSM368722.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O63///geo_accession: GSM368723///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368723/GSM368723.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O64///geo_accession: GSM368724///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368724/GSM368724.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O65///geo_accession: GSM368725///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368725/GSM368725.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O66///geo_accession: GSM368726///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368726/GSM368726.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O67///geo_accession: GSM368727///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 10///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368727/GSM368727.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O68///geo_accession: GSM368728///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368728/GSM368728.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O69///geo_accession: GSM368729///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 58///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368729/GSM368729.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O6///geo_accession: GSM368666///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368666/GSM368666.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O70///geo_accession: GSM368730///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368730/GSM368730.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O71///geo_accession: GSM368731///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 8///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368731/GSM368731.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O72///geo_accession: GSM368732///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368732/GSM368732.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O73///geo_accession: GSM368733///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: undifferentiated ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368733/GSM368733.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O74///geo_accession: GSM368734///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368734/GSM368734.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O75///geo_accession: GSM368735///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368735/GSM368735.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O76///geo_accession: GSM368736///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368736/GSM368736.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O77///geo_accession: GSM368737///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368737/GSM368737.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O78///geo_accession: GSM368738///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368738/GSM368738.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O79///geo_accession: GSM368739///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368739/GSM368739.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O7///geo_accession: GSM368667///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368667/GSM368667.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O80///geo_accession: GSM368740///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368740/GSM368740.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O8///geo_accession: GSM368668///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368668/GSM368668.cel.gz///data_row_count: 22283
1
title: ovarian cancer: O9///geo_accession: GSM368669///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 70///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368669/GSM368669.cel.gz///data_row_count: 22283
1
duplicates:
GSE14764.GSE14764_GSM368667 GSE14764.GSE14764_GSM368668
1 1
NA's
78
|
Value
An expression set
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.